Strong sterile and biologics capacity in the heart of the EU. Compare EU-GMP French CDMOs across sterile manufacturing, biologics, and drug product — by capability and site.
153 companies listed
France combines a large domestic pharmaceutical industry with a well-developed CDMO sector spanning sterile manufacturing, biologics, and drug product. Government support for reshoring strategic medicines has reinforced domestic capacity, making French sites an attractive EU manufacturing base.
French facilities operate under EU GMP, with certificates recognized across the EU and, through EMA mutual recognition agreements, accepted by the FDA and other regulators. France's strength in sterile and injectable manufacturing makes it a natural fit for vaccine, biologic, and complex-injectable programs.
For sponsors targeting both EU and US markets, French CDMOs offer EU regulatory standing alongside established export relationships, with manufacturing clusters across the Île-de-France, Rhône-Alpes, and central regions.
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
France
Our AI Matchmaker analyzes your project requirements and matches you with qualified France manufacturing partners. Free for buyers.